Pleural tuberculosis in Harare, Zimbabwe: the relationship between human immunodeficiency virus, CD4 lymphocyte count, granuloma formation and disseminated disease

被引:37
|
作者
Heyderman, RS
Makunike, R
Muza, T
Odwee, M
Kadzirange, G
Manyemba, J
Muchedzi, C
Ndemera, B
Gomo, ZAR
Gwanzura, LKZ
Mason, PR
机构
[1] Univ Zimbabwe, Sch Med, Dept Med, Harare, Zimbabwe
[2] Univ Zimbabwe, Sch Med, Dept Histopathol, Harare, Zimbabwe
[3] Univ Zimbabwe, Sch Med, Dept Chem Pathol, Harare, Zimbabwe
[4] Univ Zimbabwe, Sch Med, Dept Med Lab Technol, Harare, Zimbabwe
关键词
pleural tuberculosis; HIV; granuloma; CD4; lymphocyte; Zimbabwe;
D O I
10.1046/j.1365-3156.1998.00167.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE To elucidate the relationship between HIV, CD4(+) count and pleural TB. METHOD In a prospective study, 94 patients presenting at two large Harare hospitals with clinically suspected pleural TB were enrolled over a 10-month period. All underwent standardized evaluation, closed pleural aspiration and biopsy. Patients receiving directly observed anti-TB therapy were followed-up. RESULTS Pleural TB was diagnosed in 90 individuals (median age 33 years; range 18-65; 64 males); the seroprevalence of HIV was 85%. HIV-positive patients were older than HIV-negative individuals (median age 33 vs 23 years, P = 0.013) and had a significantly lower median CD4(+) count (191 vs 1106 x 10(6)/1 respectively, P = 0.004). A CD4(+) count of <200 x 10(6)/1 was associated with a length of illness >30 days (65% vs 37%; P = 0.05), a positive pleural fluid smear (37% vs 0%; P = 0.0006) and a positive pleural biopsy Ziehl-Neelsen stain (35% vs 7%; P = 0.021). However, a relationship between CD4(+) count and either pleural granuloma formation or radiological evidence of disseminated disease was not observed. CONCLUSION In sub-Saharan Africa, TB pleural effusions have become associated with older age, a chronic onset, and an increased mycobacterial load. These data emphasize the complex relationship between pleural TB, HIV infection and a low CD4(+) count.
引用
收藏
页码:14 / 20
页数:7
相关论文
共 50 条
  • [21] WHO clinical staging of HIV infection and disease, tuberculosis and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts
    Teck, R
    Ascurra, O
    Gomani, R
    Manzi, M
    Pasulani, O
    Kusamale, J
    Salaniponi, FML
    Humblet, P
    Nunn, R
    Scano, F
    Harries, AD
    Zachariah, R
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2005, 9 (03) : 258 - 262
  • [22] CD4 CELL COUNT CRITERIA TO DETERMINE WHEN TO INITIATE ANTIRETROVIRAL THERAPY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN
    Wongsawat, Jurai
    Puthanakit, Thanyawee
    Kanjanavanit, Suparat
    Hansudewechakul, Rawiwan
    Ngampiyaskul, Chaiwat
    Kerr, Stephen J.
    Ubolyam, Sasiwimol
    Suwanlerk, Tulathip
    Kosalaraksa, Pope
    Luesomboon, Wicharn
    Ngo-Giang-Huong, Nicole
    Chandara, Mom
    Saphonn, Vonthanak
    Ruxrungtham, Kiat
    Ananworanich, Jintanat
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (10) : 966 - 968
  • [23] Cytokine Response to AntiTubercular Therapy in Patients with Human Immunodeficiency Virus and Tuberculosis Coinfection with Respect to CD4 Count and Viral Load - A Pilot Study
    Ivaturi, Nagesh Venkata
    Sashindran, V. K.
    Singh, Anchit Raj
    Aggarwal, Vivek
    JOURNAL OF MARINE MEDICAL SOCIETY, 2022, 24 (02) : 138 - 141
  • [24] Genetic determinism in the relationship between human CD4 + and CD8 + T lymphocyte populations?
    KR Ahmadi
    MA Hall
    P Norman
    RW Vaughan
    H Snieder
    TD Spector
    JS Lanchbury
    Genes & Immunity, 2001, 2 : 381 - 387
  • [25] Cervicovaginal Cytological Abnormalities in Patients With Human Immunodeficiency Virus Infection, in Relation to Disease Stage, CD4 Cell Count and Viral Load
    Rua Micheletti, Adilha Misson
    Dutra, Valria de Freitas
    Candido Murta, Eddie Fernando
    Paschoini, Marina Carvalho
    Silva-Vergara, Mario Leon
    Barbosa e Silva, Gisele
    Adad, Sheila Jorge
    DIAGNOSTIC CYTOPATHOLOGY, 2009, 37 (03) : 164 - 169
  • [26] The Effect of Pharmaceutical Intervention on Therapeutic Adherence, Viral Load, and CD4 T Lymphocyte Count in Human Immunodeficiency Virus: An Observational Study in a Hospital Setting
    Solis-Cerdas, Hazel
    Pereira-Cespedes, Alfonso
    ARS PHARMACEUTICA, 2024, 65 (04) : 320 - 337
  • [27] Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era
    Cohen, Ronald A.
    Harezlak, Jaroslaw
    Schifitto, Giovanni
    Hana, George
    Clark, Uraina
    Gongvatana, Assawin
    Paul, Robert
    Taylor, Michael
    Thompson, Paul
    Alger, Jeffery
    Brown, Mark
    Zhong, Jianhui
    Campbell, Thomas
    Singer, Elyse
    Daar, Eric
    McMahon, Deborah
    Tso, Yuen
    Yiannoutsos, Constantin T.
    Navia, Bradford
    JOURNAL OF NEUROVIROLOGY, 2010, 16 (01) : 25 - 32
  • [28] The association of CD4 lymphocyte count with drug hypersensitivity reaction to highly active antiretroviral therapy, trimethoprim sulfamethoxazole, and antitubercular agents in human immunodeficiency virus patients
    Tarranza, Jannah Lee S.
    Ang, Maria Carmen D.
    ASIA PACIFIC ALLERGY, 2022, 12 (03)
  • [29] Correlation between CD4 count and glomerular filtration rate or urine protein:creatinine ratio in human immunodeficiency virus-infected children
    Aliyannissa, Almira
    Kuswiyanto, Rahmat Budi
    Setiabudi, Djatnika
    Nataprawira, Heda Melinda
    Alam, Anggraini
    Sekarwana, Nanan
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2020, 39 (01) : 40 - 46
  • [30] CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018
    Lee, Jennifer S.
    Humes, Elizabeth A.
    Hogan, Brenna C.
    Buchacz, Kate
    Eron, Joseph J.
    Gill, M. John
    Sterling, Timothy R.
    Rebeiro, Peter F.
    Lima, Viviane Dias
    Mayor, Angel
    Silverberg, Michael J.
    Horberg, Michael A.
    Moore, Richard D.
    Althoff, Keri N.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E2334 - E2337